ACAN and Alzheimer disease: Collectively, these findings underscore the importance of ACAN in mediating the microglial responses to Aβ pathology and highlight the potential of targeting ECM components as a therapeutic strategy to mitigate neuroinflammation and plaque accumulation in AD.